Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance

Charles River Laboratories (CRL) Tops Q4 EPS by 5c, Offers Guidance

February 14, 2024 7:04 AM EST

Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $2.46, $0.05 better than the analyst estimate of $2.41. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $991.25 million.

GUIDANCE:

Charles River Laboratories sees FY2024 EPS of $10.90-$11.40, versus the consensus of... More